Authors: | McFarland, D. C.; Saracino, R. M.; Miller, A. H.; Breitbart, W.; Rosenfeld, B.; Nelson, C. |
Article Title: | Prognostic implications of depression and inflammation in patients with metastatic lung cancer |
Abstract: | Background: Lung cancer-related inflammation is associated with depression. Both elevated inflammation and depression are associated with worse survival. However, outcomes of patients with concomitant depression and elevated inflammation are not known. Materials & methods: Patients with metastatic lung cancer (n = 123) were evaluated for depression and inflammation. Kaplan-Meier plots and Cox proportional hazard models provided survival estimations. Results: Estimated survival was 515 days for the cohort and 323 days for patients with depression (hazard ratio: 1.12; 95% CI: 1.05-1.179), 356 days for patients with elevated inflammation (hazard ratio: 2.85, 95% CI: 1.856-4.388), and 307 days with both (χ2 = 12.546; p < 0.001]). Conclusion: Depression and inflammation are independently associated with inferior survival. Survival worsened by inflammation is mediated by depression-a treatable risk factor. © 2020 Future Medicine Ltd. |
Keywords: | survival; cancer survival; treatment outcome; aged; major clinical study; cancer patient; c reactive protein; protein blood level; inflammation; cohort analysis; lung cancer; c-reactive protein; risk factor; depression; lung metastasis; immune response; clinical evaluation; depressive symptoms; cancer prognosis; immune function; prognosis; human; male; female; priority journal; article |
Journal Title: | Future Oncology |
Volume: | 17 |
Issue: | 2 |
ISSN: | 1479-6694 |
Publisher: | Future Medicine |
Date Published: | 2021-01-01 |
Start Page: | 183 |
End Page: | 196 |
Language: | English |
DOI: | 10.2217/fon-2020-0632 |
PUBMED: | 33305608 |
PROVIDER: | scopus |
PMCID: | PMC7857340 |
DOI/URL: | |
Notes: | Article -- Export Date: 1 March 2021 -- Source: Scopus |